Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis
Version 2 2024-06-04, 03:17Version 2 2024-06-04, 03:17
Version 1 2020-10-12, 08:14Version 1 2020-10-12, 08:14
conference contribution
posted on 2024-06-04, 03:17authored byS Hodgkinson, N Lizak, E Butler, J Lechner-Scott, M Slee, P McCombe, Cameron ShawCameron Shaw, O Skibina, S Vucic, N Shuey, M Barnett, J Parratt, H Butzkueven, D Jack, J Fabris, T Kalincik, VG Jokubaitis
Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis